Cancer Drug Resistance is a continuously published journal committed to the rapid publication of high quality, peer-reviewed, original researches. The journal publishes research articles, reviews, commentaries and letters on pharmacological aspects of drug resistance and its reversal, including drug design, drug delivery, drug distribution and cellular drug resistance. Molecular mechanisms of drug resistance also cover the cellular pharmacology of drug resistance such as influx and efflux pumps (including the ABC pumps), receptors and their ligands, cellular signaling pathways, drug activation and degradation (including Phase I and II metabolism), drug sequestration, target modification and DNA repair. Drug classes to be covered include DNA targeted drugs and antihormones as well as antibodies and protein kinase inhibitors. Both clinical and experimental aspects of drug resistance in cancer are included.

Aims & Scope: https://www.oaepublish.com/cdr/aims_and_scope
Author Instructions: https://www.oaepublish.com/cdr/author_instructions
Editorial Board: https://www.oaepublish.com/cdr/editor
APC statement: https://www.oaepublish.com/cdr/article_processing_charges